Dr. Mell is the Director of the Division of Clinical & Translational Research as well as the Director of the Center of Translational Radiation Medicine & Imaging (CTRMI) within the Altman Clinical Translational Research Institute. He is the Head and Neck Cancer Section Chief and is a member of the Gynecologic Malignancy Disease Team.
Dr. Mell has expertise in medical statistics and clinical trial design. He previously worked at the National Bureau of Economic Research in Palo Alto California and at the Center for Health Studies in Seattle, Washington. His primary research interests include image-guided radiation therapy (IGRT), intensity modulated radiation therapy (IMRT) and clinical trial design. He is the Principal Investigator of multiple clinical trials at UCSD, including cooperative group studies conducted by the NRG Oncology Group, and oversees several nationally and industry-funded research grants.
Co-leader of the Head and Neck Disease Team on the Moores Cancer Center Cabinet, he serves on multiple national committees in the American Society for Radiation Oncology (ASTRO), National Institutes of Health (NIH), and the Radiological Society of North America (RSNA). He is an Associate Senior Editor (Gynecology) for the International Journal of Radiation Oncology, Biology and Physics, and a member of the National Comprehensive Cancer Network (NCCN) panel for the treatment of Head/Neck malignancies.